Adia Med Inc (ADIA)
OTCMKTS · Delayed Price · Currency is USD
0.1240
-0.0040 (-3.13%)
Nov 17, 2026, 4:00 PM EST
Adia Med Revenue
Adia Med had revenue of $454.39K in the quarter ending September 30, 2026, with 284.60% growth. This brings the company's total for the last twelve months to $1.20M, up 18,674.22% year-over-year. In the year 2025, Adia Med had annual revenue of $700.51K with 10,879.75% growth. That makes Adia Med the 43,345th largest company in the world by revenue and 6,011th in the United States.
Revenue (ttm)
1.20M
Revenue Growth
+18,674.22%
P/S Ratio
9.77
Revenue / Employee
399.27K
Employees
3
Market Cap
11.71M
Revenue by Segment
- Adia Labs 448.89K 64.1%
- Adia Med 245.96K 35.1%
- Biolete 3.39K 0.5%
- Unallocated Corporate 2.27K 0.3%
Fiscal year ended Dec 31, 2025 See the full Adia Med breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 700.51K | 694.13K | 10,879.75% |
| Dec 31, 2024 | 6.38K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2004 | 197.36K | -562.56K | -74.03% |
| Dec 31, 2003 | 759.92K | 345.19K | 83.23% |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Regional Health Properties | 90.63M |
| Veltex | 70.13M |
| Mid-Atlantic Home Health Network | 27.00M |
| Syra Health | 8.96M |
| Numinus Wellness | 4.97M |
| Elite Health Systems | 3.73M |
| Stem Cell Authority | 3.33M |
| Xcelerate | 2.70M |
Adia Med News
- 1 day ago - ADIA Med Nearly Doubles Nine-Month Revenue to Surpass $1 Million - Newsfile Corp
- 9 days ago - Adia Med CEO Larry Powalisz Issues Open Letter on Leadership Journey, Research Mission, and Progress Since 2024 - Newsfile Corp
- 23 days ago - Adia Med Reports No Serious Adverse Events in First Cohort of Pediatric Autism Study; Enrollment Continues - Newsfile Corp
- 4 weeks ago - Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in Cash - Newsfile Corp
- 5 weeks ago - Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial Position - Newsfile Corp
- 6 weeks ago - Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million - Newsfile Corp
- 7 weeks ago - Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line - Newsfile Corp
- 1 month ago - Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products - Newsfile Corp